Environmental impacts and consumer concerns have necessitated the study of bio-based
materials as alternatives to petrochemicals for packaging applications. The purpose of this …

Antimicrobial peptides hold promise to supplement small molecules antibiotics and combat
the multidrug resistant microbes. There are however technical hurdles towards the clinical …

To achieve targeted treatment with fewer adverse effects against fatal cancer diseases, the
use of nanoparticles as therapeutic agents or drug carriers has been proved to be very …

The fast progress in nanomedicine and nanoparticles (NP) materials presents
unconventional solutions which are expected to revolutionise health care with great …

Introduction During the last decades, the ever-increasing proportion of patients with cancer
has been led to serious concerns worldwide. Therefore, the development and use of novel …

Advancements in biotechnology and protein engineering expand the availability of various
therapeutic proteins including vaccines, antibodies, hormones, and growth factors. In …

Microbial infection is a critical public health problem, owing to its strong infectivity and high
risk of mortality. Multi-antibiotic resistant pathogens reduce the efficacy of commercial …

With continual rapid developments in the biomedical field and understanding of the
important mechanisms and pharmacokinetics of biological molecules, controlled drug …

Albumin is a biocompatible, non-immunogenic and versatile drug carrier system. It has been
widely used to extend the half-life, enhance stability, provide protection from degradation …

Chimeric antigen receptor T cell (CAR T cell) therapy is a revolutionary approach approved
by the FDA and EMA to treat B cell malignancies and multiple myeloma. The production of …